Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Tacalcitol Monohydrate: From VDR to Translation
2026-08-28
Tacalcitol monohydrate is a synthetic analog of vitamin D3 with a translational profile spanning VDR biology, dermatology, NGF induction, and colorectal cancer research. This article connects mechanistic evidence with practical study design for evaluating its role in psoriasis models and the enhancement of 5-fluorouracil anticancer activity.
-
Cell Senescence β-Galactosidase Staining Kit Guide
2026-08-28
Learn how the Cell Senescence β-Galactosidase Staining Kit converts SA-β-Gal activity into an interpretable blue signal. This guide connects assay chemistry, senolytic screening, controls, and orthogonal validation for more rigorous senescent cell detection.
-
QX77 Workflow for Chaperone-Mediated Autophagy
2026-08-27
QX77 provides a practical way to probe LAMP2A-linked chaperone-mediated autophagy while monitoring Rab11-dependent trafficking and embryonic stem cell differentiation. This workflow connects lysosomal receptor regulation with controlled cell-state assays, without assuming that an autophagy response is automatically beneficial.
-
Y-27632 Dihydrochloride for Spatial Cell Assays
2026-08-27
Y-27632 dihydrochloride is a selective ROCK inhibitor that can add mechanistic control to modern cell-patterning and microfabrication experiments. This guide connects Rho–ROCK biology with rapid, microscope-based assay engineering while distinguishing established evidence from practical workflow proposals.
-
Carrier-Platin Triggers Rapid ROS-Driven Cancer Cell Death
2026-08-26
Liu and colleagues describe carrier-platin, a poly(amino acids)-based platinum nanotherapeutic that confines ultrasmall Pt nanoparticles and produces a rapid intracellular ROS burst. The study reports DNA-damage-independent cancer cell killing that is distinct from both apoptosis and ferroptosis, with activity in multidrug-resistant models and limited systemic toxicity in the tested preclinical settings.
-
CNO and the GPe Circuit: From Control to Translation
2026-08-26
Clozapine N-oxide (CNO) is more than a DREADDs activator: it is a strategic tool for testing whether disease-associated neural ensembles are causal, reversible, and therapeutically actionable. New findings in levodopa-induced dyskinesia illustrate how chemogenetic reactivation can turn circuit mapping into translational target validation.
-
TAI-1 Hec1 Inhibitor: Assays and Workflows
2026-08-25
TAI-1 provides a practical way to connect Hec1–Nek2 disruption with mitotic failure, cancer cell proliferation inhibition, and apoptotic cell death induction. This guide presents dose-response, imaging, combination-treatment, and RB1-aware workflows for triple negative breast cancer research, liver cancer research, and organoid-based studies.
-
MLN4924 HCl salt: Practical Assay Workflows
2026-08-25
MLN4924 HCl salt enables time-resolved interrogation of NAE-dependent neddylation, cullin-RING ligase activity, protein turnover, and cell-cycle phenotypes. This workflow-focused guide also shows how the compound can extend viral immunity studies by testing whether SCF-dependent RIPK3 degradation requires an intact neddylation pathway.
-
KN-62: A Causal Lens on Calcium-Signaling Assays
2026-08-24
KN-62 is a selective CaMKII inhibitor that can help researchers separate calcium-dependent signaling from downstream synaptic and cellular outcomes. This article develops an assay-centered framework linking KN-62 mechanism, secretase-dependent Neuroligin 1 signaling, and rigorous interpretation of calcium pathway experiments.
-
10058-F4: c-Myc-Max Inhibition Workflows
2026-08-24
10058-F4 enables time-resolved studies of c-Myc/Max-dependent transcription, mitochondrial apoptosis, leukemia differentiation, and TERT regulation. This practical guide connects assay design with recent stem-cell chromatin findings while emphasizing formulation, controls, and model-specific troubleshooting.
-
10058-F4 c-Myc-Max Dimerization Inhibitor Guide
2026-08-23
10058-F4 turns c-Myc/Max disruption into a practical workflow spanning transcriptional assays, apoptosis profiling, acute myeloid leukemia research, and prostate cancer models. This guide pairs product-handling guidance with evidence-aware strategies for connecting c-Myc biology to emerging APEX2–TERT questions without overstating the data.
-
Testosterone Bounce and Prognosis After Degarelix
2026-08-22
A 2024 retrospective study found that a testosterone bounce, defined by recovery from a nadir below 20 ng/dL to a subsequent maximum of at least 20 ng/dL, was associated with better overall and cancer-specific survival in prostate cancer patients receiving degarelix. The finding suggests that serial testosterone kinetics may complement PSA-based assessment, although prospective validation and assay standardization are still needed.
-
10058-F4: Practical c-Myc-Max Inhibition Workflows
2026-08-22
Use 10058-F4 to connect c-Myc:MAX disruption with apoptosis, leukemia differentiation, and TERT regulation in human pluripotent stem cells. This workflow-focused guide covers compound handling, assay design, mechanistic controls, and troubleshooting for cell-based and translational studies.
-
Cyclopamine Workflow for Hedgehog Cancer Studies
2026-08-21
Cyclopamine is a practical Hedgehog signaling inhibitor for connecting Smoothened blockade with proliferation, apoptosis, and developmental phenotypes. This workflow emphasizes dose design, pathway-specific controls, orthogonal readouts, and careful interpretation when extending cancer assays toward epigenetic or neuroinflammatory research.
-
Cytarabine and Cell Death: From DNA Damage to Translation
2026-08-20
Cytarabine (AraC) is more than a conventional nucleoside analog DNA synthesis inhibitor: it is a translational probe for linking deoxycytidine kinase activation, replication stress, p53 signaling, and apoptosis. This article shows how that framework can be extended—carefully and without overclaiming—to research on virus-regulated necroptosis and RIPK3 degradation.